Answers for Autism

Mom Of Three Testimonial

"I was introduced to TruDOSE™ in the beginning of 2023. Several Zoom calls later, lots of questions asked, and lots of questions answered, my husband and I decided we needed to give TruDOSE™ a try. February 22, 2023, was the first dose for William, Wyatt, my husband Adam, and myself. To our amazement we had a small nugget of hope pop up immediately after treatment with Wyatt. From that day forward it's been a launchpad of speech, development and huge gains for him. In the midst of Wyatts blooming progress, we realized that sensory issues our oldest once displayed had dwindled to nothing. We saw astonishing progress in our older boys and my husband and I were experiencing hea Ii ng ourselves.

We discovered that our then 2 year old had terrible eyesight with a negative 15 prescription. After reaching out once again to our Pediatrician and Tapley, we felt that TruDOSE™ was worth trying with our youngest. To the bewilderment of both his optometrist and ophthalmologist, Waylon's eyesight improved a total of 5 diopter points in less than two months-which caused him to need a new set of glasses. TruDOSE™ has been instrumental for growth and healing as well as a beacon of hope for my whole family."

TruDOSE™ Testimonials"

Rewiring the Neurologically Injured Brain

Whether the condition is autism, dyslexia, seizures, cerebral palsy, mental disorders, or any other neurologically injured brain condition, they are all characterized within the medical literature as having visible disruption to the blood vessel and neuron architecture of the brain. When these blood vessels and neurons become injured, your body adjusts by sprouting ones from the injured ones. In a sense, your body created a rewiring hack. However, these rewiring hacks are not the original connections and therefore you have neurological spectrum disorders of all kinds.

Your platelets carry all kinds of growth factors for healing. Surprisingly, they are the only thing in the body that carries the two growth factors specifically needed for new blood vessel formation (VEGF) and new neuron growth (BDNF). When you infuse a dose specific, high concentration of your platelets back into the blood stream, your platelets not only restart your body’s repair and immune system but have a system priority to fix neurological things first.

From 2 year old infants to 98 year old adults, the TruDOSE™ IV platelet therapy has treated thousands of neurological injured people and reversed conditions you thought were not possible to reverse. And we have the brain data to prove it! In addition, part of our long term data collection has been patient journals and interviews…thousands of them, especially the neurologically injured. Literally, the only way these patients can articulate or describe the healing effects of the TruDOSE™ IV platelet therapy is doing to their body is by saying, “It feels like it's rewiring my brain.” And we’ve heard that a thousand times.

All Star Video with Incredible Testimonials"

Tapley Holland and Dr. Naidoo

For more information about TruDOSE™ click one of the buttons below

I'd like to offer TruDOSE™ in my clinic.

I'm a Clinic

I'm a patient and would like more info about TruDOSE™

I'm a Patient

This web site is provided for educational and informational purposes about platelet therapy and does not constitute providing medical advice or professional services. All information provided on this website is from physician observational evidence or patient testimonials and not published clinical studies or clinical trials. As such, this information should not be used for diagnosing or treating a health problem or disease. Individuals seeking personal medical advice should consult with a licensed physician. Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. No physician-patient relationship is created by this web site or its use.

As of June 1, 2021, the FDA updated their guidance on all “stem cell regenerative” therapies. The FDA makes a clear distinction on the use of autologous (from you) platelet therapies compared to donor cell therapies (cells not from you). The FDA1 states: “This guidance also does not apply to products that fall outside the definition of HCT/P in 21 CFR 1271.3(d). For example, platelet rich plasma (PRP, blood taken from an individual and given back to the same individual as platelet rich plasma) is not an HCT/P under 21 CFR Part 1271 because it is a blood product. Accordingly, FDA does not apply the criteria in 21 CFR 1271.10(a) to PRP, and PRP is outside the scope of this guidance.